| Absorption |
| Blood-Brain Barrier | BBB- | 0.9659 |
| Human Intestinal Absorption | HIA- | 0.9308 |
| Caco-2 Permeability | Caco2- | 0.7539 |
| P-glycoprotein Substrate | Substrate | 0.6404 |
| P-glycoprotein Inhibitor | Non-inhibitor | 0.7322 |
| Non-inhibitor | 0.5977 |
| Renal Organic Cation Transporter | Non-inhibitor | 0.9491 |
| Distribution |
| Subcellular localization | Mitochondria | 0.4007 |
| Metabolism |
| CYP450 2C9 Substrate | Non-substrate | 0.7992 |
| CYP450 2D6 Substrate | Non-substrate | 0.8785 |
| CYP450 3A4 Substrate | Substrate | 0.5496 |
| CYP450 1A2 Inhibitor | Non-inhibitor | 0.9046 |
| CYP450 2C9 Inhibitor | Non-inhibitor | 0.9410 |
| CYP450 2D6 Inhibitor | Non-inhibitor | 0.9444 |
| CYP450 2C19 Inhibitor | Non-inhibitor | 0.9210 |
| CYP450 3A4 Inhibitor | Non-inhibitor | 0.9381 |
| CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.9840 |
| Excretion |
| Toxicity |
| Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.9777 |
| Non-inhibitor | 0.7887 |
| AMES Toxicity | Non AMES toxic | 0.9133 |
| Carcinogens | Non-carcinogens | 0.9682 |
| Fish Toxicity | High FHMT | 0.8066 |
| Tetrahymena Pyriformis Toxicity | High TPT | 0.9934 |
| Honey Bee Toxicity | High HBT | 0.5228 |
| Biodegradation | Not ready biodegradable | 0.9414 |
| Acute Oral Toxicity | III | 0.7227 |
| Carcinogenicity (Three-class) | Non-required | 0.4873 |